Therefore, the ATR-Chk1 and ATM-Chk2 DDR pathways play crucial roles in determination of susceptibility to BC in CML (Figure 1a). The gene discussed is CHEK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.